These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12796380)

  • 1. Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma.
    Zhang ZW; Newcomb P; Hollowood A; Feakins R; Moorghen M; Storey A; Farthing MJ; Alderson D; Holly J
    Clin Cancer Res; 2003 Jun; 9(6):2151-6. PubMed ID: 12796380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
    Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
    Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
    Kim JG; Sohn SK; Chae YS; Song HS; Kwon KY; Do YR; Kim MK; Lee KH; Hyun MS; Lee WS; Sohn CH; Jung JS; Kim GC; Chung HY; Yu W
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):355-60. PubMed ID: 19052714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
    Wang YC; Chen CY; Chen SK; Chang YY; Lin P
    Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
    Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
    Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
    Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
    Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan.
    Wu MT; Chen MC; Wu DC
    Cancer Lett; 2004 Mar; 205(1):61-8. PubMed ID: 15036662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.
    Boltze C; Roessner A; Landt O; Szibor R; Peters B; Schneider-Stock R
    Int J Oncol; 2002 Nov; 21(5):1151-4. PubMed ID: 12370767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P; Sengupta S
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
    Jiang P; Liu J; Zeng X; Li W; Tang J
    Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of p53 genotypes in oral cancer patients from India.
    Tandle AT; Sanghvi V; Saranath D
    Br J Cancer; 2001 Mar; 84(6):739-42. PubMed ID: 11259085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
    Lee JM; Shun CT; Wu MT; Chen YY; Yang SY; Hung HI; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
    Mutat Res; 2006 Feb; 594(1-2):181-8. PubMed ID: 16318864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
    Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
    Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
    Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
    Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients.
    Mojtahedi Z; Haghshenas MR; Hosseini SV; Fattahi MJ; Ghaderi A
    Indian J Cancer; 2010; 47(1):31-4. PubMed ID: 20071787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer.
    Ghasemi N; Karimi-Zarchi M; Mortazavi-Zadeh MR; Atash-Afza A
    Cancer Genet Cytogenet; 2010 Jan; 196(2):167-70. PubMed ID: 20082853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline polymorphism of p53 codon 72 in gynecological cancer.
    Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
    Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.